Use of Galectin-3 to promote the re-epithelialization of wounds

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S012200, C514S023000, C530S350000

Reexamination Certificate

active

06967021

ABSTRACT:
Methods for the therapeutic treatment of epithelial wounds in mammals comprising administering to a mammal afflicted with an epithelial wound a therapeutically effective amount of a galectin-3 protein and/or a galectin-7 protein are provided. Pharmaceutical compositions comprising a pharmaceutically suitable carrier or diluent and as an active agent a galectin-3 protein and/or a galectin-7 protein are also provided.

REFERENCES:
patent: 6310270 (2001-10-01), Huang et al.
patent: 2002/0044932 (2002-04-01), Liu et al.
Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends Biotechnol. 18(1):34-9, 2000.
Attwood TK. Genomics. The Babel of bioinformatics. Science. 290(5491):471-473, 2000.
Metzler et al . Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28. Nat Struc Biol. 4(7):527-531, 1997.
“The role of galectin-3 in corneal epithelial cell migration and wound healing”, Cao et al. Abstract published inInvest. Opth. Vis. Sci., 41:S682, 2000 (Mar.) and poster # B727 presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology on May 3, 2000.
“The role of galectin-3 in corneal epithelial cell migration and wound healing”, Cao et al. Abstract published inGlycobiology, 10:1088, 2000 (Oct.) and talk presented at the Annual Conference of the Society for Glycobiology on Nov. 11, 2000.
“Comparison of gene expression patterns of normal and healing corneas using cDNA microarrays”, Cao et al. Abstract published inInvest. Opth. Vis. Sci., 42:S584, 2001 (Mar.) and poster # B278 presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology on May 2, 2001.
“Galectin-3 stimulates re-epithelialization of corneal wounds”, Amin et al. Abstract published inInvest. Opth. Vis. Sci., 42:S889, 2001 (Mar.) and poster # B789 presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology on May 3, 2001.
“Impaired corneal epithelial wound closure in galectin-3 deficient mice”, Panjwani et al. Abstract published inInvest. Opth. Vis. Sci., 42:S936, 2001 (Mar.) and talk presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology on May 4, 2001.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of Galectin-3 to promote the re-epithelialization of wounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of Galectin-3 to promote the re-epithelialization of wounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of Galectin-3 to promote the re-epithelialization of wounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3468787

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.